We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo ADLM 2025 Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Molecular Diagnostics

Image: BD Rhapsody TCR/BCR multiomic assay advances immunology research capabilities in multiomics (Photo courtesy of BD)

New BD Assay Speeds Discovery in Autoimmune Disorders, Immuno-Oncology, and Infectious Diseases

Becton, Dickinson and Company (BD Franklin Lakes, NJ, USA) has launched the BD Rhapsody TCR/BCR Multiomic Assay, an innovative set of reagents that enables researchers to more easily and comprehensively analyze important cells in the immune system, providing a tool to advance research in autoimmune disorders, immuno-oncology and infectious diseases. More...
22 Apr 2022
Image: A new study has affirmed a useful blood biomarker for group of brain disorders (Photo courtesy of Mayo Clinic)

Testing for Protein in Blood Receives More Support as Biomarker for Brain Disorders

Frontotemporal dementia (FTD) is a group of brain disorders characterized by changes in behavior, cognition, language or movement that has few treatment options. These disorders involve degeneration and shrinkage of the frontal and temporal lobes of the brain. Now, a test of protein in the blood has received further support as a biomarker for patients diagnosed with FTD. More...
21 Apr 2022
DIASOURCE (A Biovendor Company)
Image: A blood test could help diagnose skin cancer (Photo courtesy of Pexels)

Blood Test to Diagnose Skin Cancer May Help Avoid Invasive Skin Biopsies

Recent advances in liquid biopsy have proposed less-invasive alternatives for cancer diagnosis and monitoring using minimal invasion at sample collection, and circulating tumor cells (CTCs) have been considered a promising blood-based surrogate marker of primary tumors. Now, new research indicates that testing an individual’s blood can reveal the presence of CTCs. Such tests may allow patients to forego invasive skin biopsies to determine whether they have skin cancer. More...
21 Apr 2022
Image: The LUNA-FL Dual Fluorescence Cell Counter (Photo courtesy of Logos Biosystems)

Tumor Suppressor Adenomatous Polyposis Coli Regulates T Lymphocyte Migration

Familial adenomatous polyposis (FAP) is an autosomal dominant inherited disease that often results from germline mutations in the adenomatous polyposis coli (APC) gene, a tumor suppressor and polarity regulator. APC protein regulates the Wnt/β-catenin signaling pathway as a component of the β-catenin destruction complex. More...
20 Apr 2022
Image: Position of tRF-gln-ttg-006 in the cloverleaf secondary structure (left) and its inhabited ability for colony formation of two HCC cell lines (right) (Photo courtesy of Higher Education Press Limited Company)

A Novel Small RNA Biomarker for Early Liver Cancer Diagnosis

A team of Chinese researchers has found evidence suggesting that a serum tsRNA (tRNA-derived small RNA) signature may serve as a novel biomarker for hepatocellular carcinoma (HCC). More...
20 Apr 2022
Image: Genetron has received CE Mark for its human B lymphocyte minimal residual disease detection kit (Photo courtesy of Genetron Health)

NGS Technology-Based Assay Detects Minimal Residual Disease in Patients with Lymphatic Hematological Tumors

A new assay based on high-throughput next generation sequencing (NGS) technology can test the CDR3 regional sequence of the IgH/K/L gene of the B cell receptor (BCR) in bone marrow samples collected from patients with B lymphpocytic leukemia (B-ALL/CLL) and multiple myeloma (MM) before and after the treatment. More...
20 Apr 2022
Image: New PCR test for oral cancer is set to revolutionize diagnosis and treatment (Photo courtesy of Pexels)

World’s First Rapid Oral Cancer Test to Revolutionize Diagnosis and Treatment

Researchers at Queen Mary University of London (London, UK) have developed the world’s first PCR test for mouth cancer that may improve the early detection of oral cancer. The test is quick and easy. It only needs the PCR machine used in COVID testing and a technician to operate it. It could be rapidly rolled out around the world at very little extra cost. More...
14 Apr 2022
New
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Silver Member
Quality Control Material
Multichem ID-B
New
Rapid Test Reader
DIA5000


Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.
PURITAN MEDICAL